The rising interest in GLP-1 agonists for diabetes has led to a debate about application forms : skin-applied devices versus capsules. Typically, GLP-1 treatments were only available in oral form, but the https://katrinavjru339741.blog-kids.com/41386614/glp-1-skin-applications-vs-tablets-is-best-for-the-patient